We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 5,873 results
  1. Viral and host mediators of non-suppressible HIV-1 viremia

    Non-suppressible HIV-1 viremia (NSV) is defined as persistent low-level viremia on antiretroviral therapy (ART) without evidence of ART non-adherence...

    Abbas Mohammadi, Behzad Etemad, ... Jonathan Z. Li in Nature Medicine
    Article Open access 13 November 2023
  2. The kinetics of SARS-CoV-2 viremia in COVID-19 patients receiving remdesivir

    Detection of SARS-CoV-2 RNA in serum, viremia, has been linked to disease severity and outcome. The kinetics of viremia in patients receiving...

    Anders Krifors, Linda Karlsson, ... Paul Skorup in European Journal of Clinical Microbiology & Infectious Diseases
    Article Open access 27 May 2023
  3. HIV viremia contributes to neurocognitive impairments in persons who use cocaine

    Persons with HIV (PWH) who use illicit drugs are at elevated risk for neurocognitive impairment (NCI). This study investigated the effects of HIV...

    Kareem Al-Khalil, Sheri L. Towe, ... Christina S. Meade in Journal of NeuroVirology
    Article 01 March 2023
  4. Recurrent parvovirus B19 viremia resulting in two episodes of hemophagocytic lymphohistiocytosis

    Background

    Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory condition with uncontrolled activation of lymphocytes and macrophages....

    Hans Martin Orth, Andre Fuchs, ... Tom Luedde in Virology Journal
    Article Open access 25 June 2022
  5. A Cell Membrane Fusion Assay for the Fish Pathogen Spring Viremia of Carp Virus (SVCV)

    Fusion of the infected cell membranes is a characteristic effect of a wide number of viral infections. Spring viremia of carp virus (SVCV), a...
    Ainhoa Gómez-Quintanilla, David Talavera, Luis Perez in Virus-Host Interactions
    Protocol 2023
  6. A recombinant measles virus vaccine strongly reduces SHIV viremia and virus reservoir establishment in macaques

    Replicative vectors derived from live-attenuated measles virus (MV) carrying additional non-measles vaccine antigens have long demonstrated safety...

    Patrycja Nzounza, Grégoire Martin, ... Frédéric Tangy in npj Vaccines
    Article Open access 22 October 2021
  7. Gut microbiome signatures linked to HIV-1 reservoir size and viremia control

    Background

    The potential role of the gut microbiome as a predictor of immune-mediated HIV-1 control in the absence of antiretroviral therapy (ART) is...

    Alessandra Borgognone, Marc Noguera-Julian, ... Tomáš Hanke in Microbiome
    Article Open access 11 April 2022
  8. Correlation between low-level viremia and hepatitis B-related hepatocellular carcinoma and recurrence: a retrospective study

    Background

    Low-level viremia generally refers to detectable HBV DNA levels lower than 2000 IU/mL. Studies show that low-level viremia is a risk factor...

    Furong Sun, Zhifei Liu, Bingyuan Wang in BMC Cancer
    Article Open access 14 October 2021
  9. Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy

    Background

    No study has comparing hepatitis B virus (HBV) relapse rates among patients with both cancer and hepatitis B e antigen (HBeAg)-negative...

    Hsin-Wei Fang, Po-Lin Tseng, ... Chien-Hung Chen in Virology Journal
    Article Open access 03 April 2024
  10. Mechanisms of Tick-Borne Virus Transmission

    The simplistic concept of an arbovirus is one centered around viremia: an infected vertebrate host with sufficient virus circulating in its blood to...
    Chapter 2023
  11. Immune response induced by standard and fractional doses of 17DD yellow fever vaccine

    The re-emergence of yellow fever (YF) urged new mass vaccination campaigns and, in 2017, the World Health Organization approved the use of the...

    Thais Abdala-Torres, Ana Carolina Campi-Azevedo, ... Lis Ribeiro do Valle do Antonelli in npj Vaccines
    Article Open access 08 March 2024
  12. Neutralizing antibodies targeting a novel epitope on envelope protein exhibited broad protection against flavivirus without risk of disease enhancement

    Background

    Flavivirus causes many serious public health problems worldwide. However, licensed DENV vaccine has restrictions on its use, and there is...

    Li-Chen Yen, Hsin-Wei Chen, ... Ching-Len Liao in Journal of Biomedical Science
    Article Open access 14 June 2023
  13. High prevalence and viremia of human pegivirus 2 in the HIV-infected population in Honghe Prefecture, Yunnan Province

    Human pegivirus 2 (HPgV-2) is a recently recognized pegivirus of the family Flaviviridae. To investigate the epidemic features of HPgV-2 circulating...

    Tianyi Li, Shixing Tang, ... **gyun Li in Archives of Virology
    Article 21 January 2020
  14. Immune reconstitution inflammatory syndrome drives emergence of HIV drug resistance from multiple anatomic compartments in a person living with HIV

    Reservoirs of HIV maintained in anatomic compartments during antiretroviral therapy prevent HIV eradication. However, mechanisms driving their...

    Andrea Lisco, Camille Lange, ... Irini Sereti in Nature Medicine
    Article 15 June 2023
  15. Determining host factors contributing to the reactivation of JC virus in kidney transplant recipients

    Background and aims

    The John Cunningham virus (JCV) is the established etiological agent of the polyomavirus-associated nephropathy among renal...

    Sajedeh Keykhosravi, Masoud Khosravi, ... Tolou Hasandokht in Virology Journal
    Article Open access 08 August 2022
  16. AZD5582 plus SIV-specific antibodies reduce lymph node viral reservoirs in antiretroviral therapy-suppressed macaques

    The main barrier to HIV cure is a persistent reservoir of latently infected CD4 + T cells harboring replication-competent provirus that fuels rebound...

    Amir Dashti, Sophia Sukkestad, ... Ann Chahroudi in Nature Medicine
    Article Open access 02 October 2023
  17. MVA-based vaccines are protective against lethal eastern equine encephalitis virus aerosol challenge in cynomolgus macaques

    MVA-based monovalent eastern equine encephalitis virus (MVA-BN-EEEV) and multivalent western, eastern, and Venezuelan equine encephalitis virus...

    Brandon J. Beddingfield, Kenneth S. Plante, ... Chad J. Roy in npj Vaccines
    Article Open access 27 February 2024
  18. Dynamics and durability of HIV-1 neutralization are determined by viral replication

    Human immunodeficiency virus type 1 (HIV-1)-neutralizing antibodies (nAbs) that prevent infection are the main goal of HIV vaccine discovery. But as...

    Philipp Schommers, Dae Sung Kim, ... Florian Klein in Nature Medicine
    Article Open access 13 November 2023
  19. A replicating RNA vaccine confers protection in a rhesus macaque model of Crimean-Congo hemorrhagic fever

    Crimean-Congo hemorrhagic fever (CCHF) is a tick-borne febrile illness with a wide geographic distribution. In recent years the geographic range of...

    David W. Hawman, Shanna S. Leventhal, ... Heinz Feldmann in npj Vaccines
    Article Open access 20 May 2024
Did you find what you were looking for? Share feedback.